Toxicidad pulmonar por dasatinib / Dasatinib-Related Pulmonary Toxicity
Rev. am. med. respir
;
22(2): 170-172, jun. 2022. ilus
Article
in Spanish
| LILACS, BINACIS
| ID: biblio-1441123
RESUMEN
Paciente de sexo masculino, 70 años, con leucemia mieloide crónica en tratamiento con dasatinib, desarrolla insuficiencia respiratoria asociada a toxicidad pulmonar por dicho fármaco.
ABSTRACT
70-year-old male patient with chronic myeloid leukemia receiving treatment with da satinib develops respiratory failure associated with pulmonary toxicity related to such drug.
Full text:
Available
Index:
LILACS (Americas)
Language:
Spanish
Journal:
Rev. am. med. respir
Journal subject:
Medicine
/
Pulmonary Disease (Specialty)
Year:
2022
Type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Hospital Nacional Prof. Dr. Alejandro Posadas/AR
Similar
MEDLINE
...
LILACS
LIS